Gartner Research

Risk Management in Life Sciences Requires Protecting Both Your Company and Your Patient

Published: 29 June 2017

ID: G00328704

Analyst(s): Stephen Meyer

Summary

Life science supply chains must insulate both their companies and patients from disruptive events. However, typical risk management practices do not have a broad enough scope to do so. Supply chain leaders involved in life sciences can use this research to improve their risk management process.

Table Of Contents

Analysis

  • Risk Management in the Life Sciences Industry
  • Life Sciences Supply Chains Must Insulate Their Companies and Their Patients From Risk Simultaneously
    • Protect the Company
    • Protect the Patient

Gartner Recommended Reading

©2019 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client